Top Story

ASCO elects 2016 president

January 24, 2015

Daniel F. Hayes, MD, FASCO, will serve as president of ASCO for the term beginning in June 2016.

He will become president-elect during the society’s annual meeting in June 2015.

Institution Notes

University of Pittsburgh appoints director of stem cell transplantation

January 23, 2015
Warren Shlomchik, MD, has been named director of stem cell transplantation and cell therapies for the University of Pittsburgh’s division of hematology-oncology…
Meeting News Coverage

MM-398 improved outcomes in metastatic pancreatic cancer

January 23, 2015
The addition of the novel agent MM-398 to second-line 5-FU/leucovorin extended survival in patients with metastatic pancreatic cancer, according to an expanded analysis…
In the Journals

Keratinization may be prognostic in certain head and neck cancers

January 23, 2015
Keratinization may be prognostic for patients with oropharyngeal squamous cell carcinoma, according to results of a retrospective, cross-sectional study.The greatest…
Health Care Legislative and Regulatory Update

New year, new code: How to get paid for chronic care management in 2015, part 3

January 23, 2015
Beginning in 2015, physicians and other qualified health care professionals will be able to separately bill Medicare for providing non-face-to-face chronic care…
More News Headlines »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »